FindTrial
Sign In

Efficacy of Dexamethasone vs Dexmedetomidine as an Adjuvant to Ropivacaine in Transverse Abdominis Plane Block for Postoperative Pain Relief

Comparison of Analgesic Efficacy of Dexamethasone versus Dexmedetomidine as an adjuvant to Ropivacaine in Ultrasound guided transverse Abdominis Plane Block for postoperative pain relief in lower abdominal surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053454
Enrollment
90
Registered
2023-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Dexamethasone as an adjuvant to Ropivacaine: USG TAP block bilaterally with 20ml of 0.2% isobaric ropivacaine along with 0.1mg/kg dexamethasone on each side will be given in Group A to

Sponsors

MANISHA SHARMA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients- 1) Above 18 years of age 2) undergoing elective lower abdominal surgeries under spinal anaesthesia. 3) American Society of Anaesthesiology (ASA) grade I or II 4) BMI 20-30 Kg/m2 5) Who could understand and rate their pain on Visual Analog Scale (VAS; scale of 0â??10) 6) Provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients who 1) Were unwilling to participate in the study 2) BMI >30 Kg/m2 3) Had a history of allergy with ropivacaine or dexamethasone or dexmedetomidine use 4) Had a history of drug abuse 5) Were unable to understand VAS 6) Had coagulopathy or risk of developing same. 7) Who did not tolerate spinal anaesthesia well and had to be converted to general anaesthesia for surgery. 8) Had surgery planned with general anaesthesia 9) Could not provide informed consent

Design outcomes

Primary

MeasureTime frame
To the compare the analgesic efficacy of dexamethasone versus dexmedetomidine as an adjuvant to ropivacaine in TAP Block for postoperative pain relief in Lower Abdominal Surgeries.Timepoint: 2weeks,4weeks,6weeks—

Secondary

MeasureTime frame
To evaluate the analgesic efficacy of dexamethasone as an adjuvant to ropivacaine in TAP Block for postoperative pain relief in Lower Abdominal Surgeries. 2. To evaluate the analgesic efficacy of dexmedetomidine as an adjuvant to ropivacaine in TAP Block for postoperative pain relief in Lower Abdominal Surgeries. Timepoint: 2weeks,4weeks,6weeks—

Countries

India, Malaysia

Contacts

Public ContactMANISHA SHARMA

Varun Arjun Medical College and Rohilkhand Hospital

richanshu45@yahoo.co.in9996433949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026